The Microdose

Home
This Week in Psychedelics
5 Questions
Spotlight
Opinion
Archive
About
Conflicts of interest: 5 Questions for researcher Elena Koning
Koning discusses how conflicts of interest play out in the psychedelic research world.
 • 
jane c. hu
Revisions made to report critical of Lykos’s research on MDMA-assisted therapy; Lawsuit postpones hearing for contentious DEA proposal; and…
Plus: Alaska psychedelic task force bill passes; California research panel bill advances to senate while regulated access bill stalls; and the nocebo…
 • 
jane c. hu
Drug recriminalization in Oregon: 5 Questions for attorney Jon Dennis
Dennis discusses Oregon's recent drug recriminalization.
 • 
jane c. hu
Most Popular
View all
Welcome to The Microdose
 • Michael Pollan
66
Mixing antidepressants and psychedelics: 5 Questions for psychopharmacologist Kelan Thomas
 • jane c. hu
16
Oregon’s first psilocybin client: 5 Questions for retired home builder Jim Carroccio
 • jane c. hu
43
This is a Warning
 • Simon Moya-Smith
35
Heart risks, serotonin, and fen-phen: 5 Questions for 5-HT receptor researcher Bryan Roth
 • jane c. hu
12
New clinical trial results suggest a single psilocybin dose can significantly reduce depression symptoms for weeks; Comments on FDA’s draft…
 • jane c. hu
3
U.S. Food & Drug Administration will hold advisory committee meeting on MDMA; A psychedelics research bottleneck in California; and…
Plus: More opposition to Massachusetts’ psychedelics bill, and researchers publish consensus statement on ethics
 • 
jane c. hu
What do we know about the psychedelic underground?: 5 Questions for drugs researcher Crystal Lederhos Smith
Smith discusses a recent qualitative study in which she and her collaborators interviewed underground psychedelic practitioners about their practices…
 • 
jane c. hu
Preparing insurers and patients for MDMA-assisted therapy; NIH announces $20 million grant to study psychedelics and chronic pain; Are…
Plus: MAPS’s MDMA clinical trial team responds to critical report, and a new Compass and Journey partnership
 • 
jane c. hu
Psychedelics 101 for doctors: 5 Questions for Psychedelic Medicine Association founder Lynn Marie Morski
Morski discusses what healthcare professionals know and don’t know about psychedelics, and how her organization seeks to bridge the gap between the two.
 • 
jane c. hu
Federal agencies settle with ayahuasca church; U.S. reps urge VA to prepare for MDMA approval; CO bill could hamper psychedelics discussion…
Plus: Draft rules released for Colorado psilocybin program, and California and Missouri bills advance
 • 
jane c. hu
Hasidic Judaism and Psychedelics: 5 Questions for Jewish studies scholar Sam Shonkoff
Shonkoff discusses psychedelics’ role in the history of Hasidic Judaism, and how that role is evolving.
 • 
jane c. hu
No serious adverse reactions recorded in synthetic 5-MeO-DMT study; California psychedelics bill advances; Are medical trainees ready for…
Plus: European Medicines Agency holds psychedelics workshop and psilocybin improves psychological flexibility
 • 
jane c. hu
The Microdose
The Microdose
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics

The Microdose

AboutArchiveSitemap
© 2024 UC Berkeley Center for the Science of Psychedelics
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture